tiprankstipranks

Mark Jeffrey DeLong Insider Profile

4 Followers
Mark Jeffrey DeLong, Chief Business & Strat Officer at Apellis Pharmaceuticals, holds 60.40K shares in Apellis Pharmaceuticals (Ticker: APLS).
tipranks
Mark Jeffrey DeLong

Mark Jeffrey DeLong
Apellis Pharmaceuticals (APLS)
Chief Business & Strat Officer

Ranked #6,658 out of 99,335 Corporate Insiders

Profitable Transactions

88%
7 out of 8 Profitable Transactions

Average Return

+29.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Mark Jeffrey DeLong's holdings

Insider Roles

Apellis Pharmaceuticals
(APLS)
Chief Business & Strat Officer
Roles that Mark Jeffrey DeLong holds in companies

Most Profitable Insider Trade

Stock:
Apellis Pharmaceuticals
(APLS)
Rating:Informative Sell
Date:Jan 23, 2024 - Today
Return:+54.60%
The most profitable trade made by Mark Jeffrey DeLong

Mark Jeffrey DeLong's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Apellis Pharmaceuticals
Aug 13, 2024
Chief Business & Strat Officer
Uninformative Buy
72.03K
$1.66M
Success Rate for
APLS
7 out of 8 profitable transactions on
APLS
88%
Average Return for
APLS
Average return per transaction on
APLS
+29.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 17, 2024
Uninformative Buy
$0.00
-
$0.00
Aug 18, 2022
Uninformative Buy
$77.60K
-
$15.52
Aug 13, 2024
Uninformative Buy
$72.03K
-
$13.85
Jan 24, 2023
Uninformative Sell
$59.81K
-
$52.05
Jan 17, 2024
Informative Sell
$108.95K
-
$66.80
+54.50%
List of latest transactions for each holding click on a transaction to see Mark Jeffrey DeLong's performance on stock

Mark Jeffrey DeLong insider profile FAQ

What is the percentage of profitable transactions made by Mark Jeffrey DeLong?
The percentage of profitable transactions made by Mark Jeffrey DeLong is 88%.
    What is the average return per transaction made by Mark Jeffrey DeLong?
    The average return per transaction made by Mark Jeffrey DeLong is 29.50%.
      What stocks does Mark Jeffrey DeLong hold?
      Mark Jeffrey DeLong holds: APLS stocks.
        What was Mark Jeffrey DeLong’s latest transaction?
        Mark Jeffrey DeLong latest transaction was an Uninformative Buy of $72.03K.
          What was Mark Jeffrey DeLong's most profitable transaction?
          Mark Jeffrey DeLong’s most profitable transaction was an Informative Sell of APLS stock on January 23, 2024. The return on the trade was 54.60%.
            What is Mark Jeffrey DeLong's role in Apellis Pharmaceuticals?
            Mark Jeffrey DeLong's role in Apellis Pharmaceuticals is Chief Business & Strat Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.